Sort
50,496 grants matching “lung cancer”
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
$2,161,999John D Minna · Ut Southwestern Medical Center · P50 · FY2014 · CA
SPORE in Lung Cancer
$2,161,999James G. Herman · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,161,996Roy S Herbst · Yale University · P50 · FY2016 · CA
CENTRAL DATA COLLECTION CENTER (CDCC) CONTINUED FOLLOW-UP OF PLCO
$2,160,252Sunitha Mathew · Westat, Inc. · N01 · FY2014 · CA
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Domestic Hub
$2,157,554Edward Snyder · Yale University · N01 · FY2011 · HL
Medical University of South Carolina - Cancer Center Support Grant
$2,156,301Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2022 · CA
Medical University of South Carolina - Cancer Center Support Grant
$2,156,301Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2023 · CA
Medical University of South Carolina - Cancer Center Support Grant
$2,156,301Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2020 · CA
Medical University of South Carolina - Cancer Center Support Grant
$2,156,301Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2021 · CA
SPORE in Lung Cancer
$2,156,287Jill M Siegfried · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · CA
SPORE in Lung Cancer
$2,156,287Jill M Siegfried · University Of Pittsburgh At Pittsburgh · P50 · FY2007 · CA
SPORE in Lung Cancer
$2,156,287Jill M Siegfried · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA
SPORE in Lung Cancer
$2,156,287Jill M Siegfried · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · CA
Broad Institute Center for Cancer Systems Biology
$2,155,526Todd R. Golub · Broad Institute, Inc. · U54 · FY2012 · CA
Inorganics as Early Life Carcinogens
$2,153,695Michael Waalkes · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Cancer Risk in Human Populations
$2,153,446Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
SPORE in Lung Cancer
$2,150,500Stephen B Baylin · Johns Hopkins University · P50 · FY2013 · CA
SARC Sarcoma SPORE
$2,150,500Raphael E. Pollock · Sarc · U54 · FY2013 · CA
Targeted antigen receptor treatment of cancer
$2,150,453Alan N. Houghton · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance
$2,150,317Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
The HMS Laboratory of Systems Pharmacology
$2,149,568Peter Karl Sorger · Harvard Medical School · P50 · FY2017 · GM
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$2,148,642Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$2,148,164Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
$2,147,232Lawrence H Kushi · Kaiser Foundation Research Institute · P01 · FY2020 · CA
Studies of the SARS-CoV-2 Spike Protein
$2,147,209Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA